Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.50 is 14% above its 5-year average of 1.31, around the middle of its 5-year range (1.05–1.85).
As of the fiscal period ended Friday, July 31, 2026. 1.67% below its 12-month average of 1.52.
Reported quarterly current ratio; no daily interpolation. Q3 FY2026 (2026-07-31): 1.50.
CURRENT RATIO
1.50
CURRENT RATIO AVG TTM
1.52
CURRENT RATIO AVG 3Y
1.39
CURRENT RATIO AVG 5Y
1.31
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.67%
CURRENT VS 3Y AVG
+7.60%
CURRENT VS 5Y AVG
+14.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
-58.37%
vs the sector median at left
Market Cap
$238.48M
Current Ratio
21.72
TTM Avg
10.47
3Y Avg
8.50
5Y Avg
9.09
Market Cap
$239.69M
Current Ratio
1.43
TTM Avg
1.27
3Y Avg
1.29
5Y Avg
1.36
Market Cap
$240.04M
Current Ratio
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.68
Market Cap
$243.34M
Current Ratio
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$243.62M
Current Ratio
3.87
TTM Avg
3.17
3Y Avg
2.70
5Y Avg
2.15
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $236.81M | 1.50 | 1.52 | 1.39 | 1.31 |
| SIGA Technologies, Inc. (SIGA)vs › | $238.48M | 21.72 | 10.47 | 8.50 | 9.09 |
| MacroGenics, Inc. (MGNX)vs › | $235.13M | 2.96 | 4.51 | 4.52 | 4.67 |
| InflaRx N.V. (IFRX)vs › | $238.61M | 8.22 | 4.59 | 5.79 | 6.14 |
| BioAge Labs Inc. (BIOA)vs › | $234.14M | 17.19 | 13.55 | 8.08 | 8.08 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.69M | 1.43 | 1.27 | 1.29 | 1.36 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.04M | 4.70 | 7.13 | 7.51 | 5.68 |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | 0.10 | 1.46 | 1.56 | 2.73 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | 3.87 | 3.17 | 2.70 | 2.15 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | 1.54 | 1.17 | 19.33 | 29.22 |
Current Ratio
1.50
Quick Ratio
0.81
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-07-31 | 1.50 |
| 2026-04-30 | 1.46 |
| 2026-01-31 | 1.43 |
| 2025-10-31 | 1.37 |
| 2025-07-31 | 1.85 |
| 2025-04-30 | 1.57 |
| 2025-01-31 | 1.61 |
| 2024-10-31 | 1.40 |
| 2024-07-31 | 1.26 |
| 2024-04-30 | 1.17 |
| 2024-01-31 | 1.13 |
| 2023-12-29 | 1.18 |
| 2023-07-31 | 1.16 |
| 2023-04-30 | 1.10 |
| 2023-01-31 | 1.05 |
| 2022-10-31 | 1.07 |
| 2022-07-31 | 1.23 |
| 2022-04-30 | 1.14 |
| 2022-01-31 | 1.10 |
| 2021-10-31 | 1.13 |
| 2021-07-31 | 1.62 |
| 2021-04-30 | 1.31 |
| 2021-01-31 | 0.78 |
| 2020-10-31 | 0.70 |
| 2020-07-31 | 0.65 |
| 2020-04-30 | 0.48 |
| 2020-01-31 | 0.60 |
| 2019-10-31 | 1.18 |
| 2019-07-31 | 6.03 |
| 2019-04-30 | 4.18 |
| 2019-01-31 | 5.12 |
| 2018-10-31 | 6.76 |
| 2018-07-31 | 4.34 |
| 2018-04-30 | 0.00 |
| 2018-01-31 | 0.00 |
| 2017-10-31 | 0.50 |
| 2017-07-31 | 0.00 |
